Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition
Author:
Affiliation:
1. Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA
2. Medicine, Virginia Commonwealth University, Richmond, VA, USA
Funder
NIH general medicine
HHS | NIH | National Cancer Institute
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1538616
Reference31 articles.
1. EGF receptor mutations in lung cancer: From humans to mice and maybe back to humans
2. ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
3. The ErbB/HER family of protein-tyrosine kinases and cancer
4. Therapeutic Targeting of the Epidermal Growth Factor Receptor in Human Cancer
5. Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibitory effect of Fingolimod on head and neck squamous cell carcinoma and its mechanism: Gene set enrichment analysis;Cellular and Molecular Biology;2023-07-31
2. Effect of FTY-720 on Pulmonary Fibrosis in Mice via the TGF-β1 Signaling Pathway and Autophagy;Biomolecules & Therapeutics;2023-04-06
3. Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models;International Journal of Molecular Sciences;2022-07-25
4. Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target;Journal of Oncology;2022-06-28
5. Implications of Sphingolipids on Aging and Age-Related Diseases;Frontiers in Aging;2022-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3